Article
Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2011
Li Yafei, Sun Zhifu, Cunningham Julie M, Aubry Marie C, Wampfler Jason A, Croghan Gary A, Johnson Cassandra, Wu Danli, Aakre Jeremiah A, Molina Julian, Wang Liewei, Pankratz V Shane, Yang Ping
Abstract excerpt
PURPOSE: Variations in genes related to biological activity of anticancer drugs could influence treatment responses and lung cancer prognosis. Genetic variants in four biological pathways, that is, glutathione metabolism, DNA repair, cell cycle, and epidermal growth factor receptor (EGFR), were systematically investigated to examine their association with survival in advanced stage non-small cell lung cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
